Moderna, Inc.: Therapeutic Goods Administration Provisionally Approves Moderna's Omicron-Containing Bivalent Booster Candidate, MRNA-1273.214, For Australia
Australia becomes among the first countries in the world to approve the use of a next-generation bivalent COVID-19 vaccinemRNA-1273.214, an Omicron-containing bivalent vaccine, has demonstrated significantly